Temple University

Halfway through February, seven different sources of funding for health care and life science innovations have announced newly raised pools of cash totaling $2.2bn for a wide array of technologies, in

Ridgeback To Lead Development Of Emory University Viral Replication Inhibitor Privately held Ridgeback Biotherapeutics LP and Emory University y announced on 19 March they will work together to advan

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Spherix

Alize Pharma III Gets €67m In Series A Round Alize Pharma III SAS raised €67m ($75m) in an oversubscribed Series A financing led by LSP, which was joined by other new backers Novo Ventures, Kurma Pa